Aspira Pathlab & Diagnostics Limited (BOM:540788)
India · Delayed Price · Currency is INR 90.05
-1.80 (-1.96%)
At close: Aug 21, 2026
BOM:540788 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 0.51 | 20.23 | -26.72 | -0.89 | 44.59 |
Depreciation & Amortization | 15.38 | 14.9 | 15.12 | 15.27 | 15.79 |
Other Amortization | - | 0.04 | 0.27 | 0.58 | 0.56 |
Loss (Gain) From Sale of Assets | - | -0.32 | -0.01 | 0.04 | - |
Provision & Write-off of Bad Debts | 3.19 | 3.34 | 1.82 | 0.29 | 3.18 |
Other Operating Activities | -0.42 | -0.2 | 0.5 | 1.84 | 4.43 |
Change in Accounts Receivable | 2.99 | -4.43 | -0.86 | 21.23 | -31.06 |
Change in Inventory | -1.86 | -0.64 | -0.48 | 0.06 | -0.38 |
Change in Accounts Payable | 4.02 | 0.12 | 3.82 | -2.65 | -0.55 |
Change in Other Net Operating Assets | -9.28 | -14.75 | 17.08 | -35.91 | -16.26 |
Operating Cash Flow | 14.54 | 18.27 | 10.54 | -0.12 | 20.31 |
Operating Cash Flow Growth | -20.44% | 73.43% | - | - | -64.20% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -6.96 | -3.44 | -2.62 | -1.31 | -5.99 |
Sale of Property, Plant & Equipment | - | 1.71 | 0.02 | 0.05 | - |
Sale (Purchase) of Intangibles | -0.03 | - | -0.01 | -0.05 | -0.08 |
Investment in Securities | -7.52 | -0.8 | - | - | - |
Other Investing Activities | 6.46 | 3.69 | 4 | 2.91 | 0.95 |
Investing Cash Flow | -8.04 | 1.16 | 1.38 | 1.59 | -5.12 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 1.45 | 1.29 | 1.15 | 1.03 | 0.92 |
Total Debt Issued | 1.45 | 1.29 | 1.15 | 1.03 | 0.92 |
Short-Term Debt Repaid | - | - | - | - | -4.84 |
Long-Term Debt Repaid | -8.93 | -7.76 | -7.02 | -6.21 | -5.88 |
Total Debt Repaid | -8.93 | -7.76 | -7.02 | -6.21 | -10.71 |
Net Debt Issued (Repaid) | -7.48 | -6.47 | -5.87 | -5.18 | -9.79 |
Other Financing Activities | -3.9 | -3.47 | -3.68 | -4.17 | -3.73 |
Financing Cash Flow | -11.37 | -9.94 | -9.54 | -9.35 | -13.52 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - |
Net Cash Flow | -4.88 | 9.49 | 2.37 | -7.88 | 1.67 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 7.58 | 14.83 | 7.92 | -1.43 | 14.32 |
Free Cash Flow Growth | -48.89% | 87.32% | - | - | -74.19% |
Free Cash Flow Margin | 3.03% | 6.74% | 6.00% | -0.99% | 7.33% |
Free Cash Flow Per Share | 0.74 | 1.44 | 0.77 | -0.14 | 1.39 |
Levered Free Cash Flow | 16.37 | 21.71 | 3.73 | 29.87 | 9.51 |
Unlevered Free Cash Flow | 18.81 | 23.62 | 5.71 | 32.16 | 11.44 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 3.9 | 3.47 | 3.68 | 4.17 | 3.73 |
Change in Working Capital | -4.13 | -19.71 | 19.55 | -17.26 | -48.25 |